Also listed on Elan Pharma International Limited, an earlier holder on the record. The recorded assignments below show how it moved.
Term ends Dec 2, 2026 · Medium confidence
20-year base term ended Sep 20, 2024
Why Medium: A parent in the chain could not be resolved.
Held by Padagis US LLC
Filed Jul 23, 2012 as application 13/555,472 · Granted Oct 17, 2017
Base term plus 803 days of patent term adjustment (USPTO delay)
Today
2004
2026
Clock starts
Sep 20, 2004
Sep 20, 2004
Term ends
Dec 2, 2026
Dec 2, 2026
Granted
Oct 17, 2017
Oct 17, 2017
base term
patent term adjustment
fee events
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
803
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
None
Terminal disclaimer
No disclaimer on this record.
2 of 2
Maintenance fees paid
Two maintenance fees can end this term early, the ones due 3.5 and 7.5 years from grant; the third one's grace period runs past the term end. This counts the ones the record shows paid.
5
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.
This patent's term runs 803 days past its 20-year base term on prosecution delay. 2 of 2 maintenance fees are paid so far. Confidence: Medium. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Sep 20, 2004, when application 10/944,416, the earliest non-provisional in its chain, was filed (this one was filed Jul 23, 2012); a parent in its chain could not be resolved (the next row) | Sep 20, 2024 | High confidence |
| Continuity chain | A parent in the chain could not be resolved | dated from this application's own claim | Medium confidence |
| Patent term adjustment | +803 days, USPTO patent term adjustment record | Dec 2, 2026 | High confidence |
| Terminal disclaimer cap | None on record | no cap applied | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 2 of 2 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Dec 2, 2026 | Medium confidence |
This family
| US 9,789,057 | this patent Dec 2026 | Dec 2026 |
| Application 13/557,527 | Abandoned not computed | not computed |
2 of 5 applications in this family shown, earliest filings first. The applications whose file history this site holds. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Sep 17, 2013 Reel 31226, frame 883 | Drugtech Corporation | Law Debenture Trust Company of New York, as Agent | Security Agreement |
| Jan 31, 2014 Reel 32104, frame 506 | Riley, Thomas C.; Levinson, R. Saul; Cuca, Robert C.; Mariani, Elio | KV Pharmaceutical Company | Assignment of Assignor's Interest |
| Jan 31, 2014 Reel 32104, frame 687 | KV Pharmaceutical Company | Drugtech Corporation | Assignment of Assignor's Interest |
| Jul 9, 2014 Reel 33282, frame 265 | Drugtech Corporation | Lumara Health IP Ltd. | Change of Name |
| Oct 20, 2014 Reel 34018, frame 40 | Law Debenture Trust Company of New York | K-V Pharmaceutical Company | Release of Security Interests in Intellectual Property |
| Nov 12, 2014 Reel 34156, frame 243 | Lumara Health IP Ltd. | Jefferies Finance LLC | Security Interest |
| Nov 25, 2014 Reel 34470, frame 835 | Lumara Health IP Ltd. | Elan Pharma International Ltd. | Assignment of Assignor's Interest |
| Sep 25, 2015 Reel 36653, frame 138 | Lumara Health IP Ltd. | Jefferies Finance LLC | Security Interest |
| Dec 1, 2016 Reel 40478, frame 926 | Elan Pharma International Ltd. | Perrigo Pharma International Limited | Change of Name |
| Dec 1, 2016 Reel 40780, frame 943 | Perrigo Pharma International Limited | Perrigo Pharma International Designated Activity Company | Change of Name |
| May 15, 2017 Reel 42461, frame 626 | Jefferies Finance LLC | Lumara Health IP Ltd. | Release of Security Interest |
| Jul 7, 2021 Reel 56773, frame 863 | Padagis US LLC | JPMorgan Chase Bank, N.A., as Administrative Agent | Security Agreement |
| Jul 13, 2021 Reel 56831, frame 1 | Perrigo Pharma International Designated Activity Company | Perrigo Company | Assignment of Assignor's Interest |
| Jul 14, 2021 Reel 56851, frame 871 | Perrigo Company | Padagis US LLC | Assignment of Assignor's Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
What's changing
Dec 2026
Term ends Dec 2, 2026. No further fees fall due before then
Note
The 803 days of patent term adjustment (USPTO delay) are read from the USPTO record, not recalculated by us
Citations
2
later US patents cite this one
That is below the median of utility patents granted in 2017 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.